Clinica Pediatrica e Centro Tettamanti, Università di Milano-Bicocca, Fondazione MBBM, Ospedale San Gerardo, Monza
Indirizzo per corrispondenza: firstname.lastname@example.org
Key words: Stem cells, Mesenchymal stromal cell (MSC), Good manufacturing practice (GMP), Cell therapy
Stem cells of various origin nowadays represent a fascinating field of scientific investigation and clinical application. However, at the same time, particularly in the field of regenerative medicine, they have generated ambiguous situations, where so defined “scientific investigators” have created and alimented fake hopes in treating severe degenerative diseases. The scope of the present article is to give the readers a virtuous path by describing different clinical cases to show the complexity of the clinical use of such cells as well as the real scientific-based evidences that justify their use in the context of rigorous GMP (good manufacturing practice) regulations.
Vuoi citare questo contributo?